US Patent Issued to VIROMETIX, UNIVERSITAT ZURICH on Nov. 11 for "Lipopeptide building blocks and synthetic virus-like particles" (Swiss Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,633, issued on Nov. 11, was assigned to VIROMETIX AG (Schlieren, Switzerland) and UNIVERSITAT ZURICH (Zurich, Switzerland).

"Lipopeptide building blocks and synthetic virus-like particles" was invented by Arin Ghasparian (Zurich, Switzerland) and John A Robinson (Kemptthal, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a lipopeptide building block consisting of (i) a peptide moiety comprising a coiled coil peptide chain segment, wherein said coiled coil peptide chain segment comprises 3 to 8 repeat units, and wherein said repeat unit consists of the sequence IEKKIE-X0 (SEQ ID NO:58), wherein X0 represent...